↓ Skip to main content
What is this page? Embed badge

Cardiac Extracellular Matrix

Overview of attention for book
Cover of 'Cardiac Extracellular Matrix'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Biomechanical Properties and Mechanobiology of Cardiac ECM
  3. Altmetric Badge
    Chapter 2 Imaging the Cardiac Extracellular Matrix
  4. Altmetric Badge
    Chapter 3 Animal Models and Cardiac Extracellular Matrix Research
  5. Altmetric Badge
    Chapter 4 Applications of Cardiac Extracellular Matrix in Tissue Engineering and Regenerative Medicine
  6. Altmetric Badge
    Chapter 5 Whole Cardiac Tissue Bioscaffolds
  7. Altmetric Badge
    Chapter 6 Natural Sources of Extracellular Matrix for Cardiac Repair
  8. Altmetric Badge
    Chapter 7 Cardiac Extracellular Matrix Modification as a Therapeutic Approach
  9. Altmetric Badge
    Chapter 8 Extracellular Matrix for Myocardial Repair
  10. Altmetric Badge
    Chapter 9 Role of Extracellular Matrix in Cardiac Cellular Therapies
  11. Altmetric Badge
    Chapter 10 Regulation of Regenerative Medicine Products
  12. Altmetric Badge
    Chapter 11 Clinical Trial Design for Investigational Cardio-Regenerative Therapy
  13. Altmetric Badge
    Chapter 12 Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry
Attention for Chapter 12: Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
24 Mendeley
Summary X
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry
Chapter number 12
Book title
Cardiac Extracellular Matrix
Published in
Advances in experimental medicine and biology, September 2018
DOI 10.1007/978-3-319-97421-7_12
Pubmed ID
30238374
Book ISBNs
978-3-31-997420-0, 978-3-31-997421-7
Authors

Adam J. Bock, David Johnson, Bock, Adam J., Johnson, David

Abstract

Regenerative medicine research at university laboratories has outpaced commercial activity. Legal, regulatory, funding, technological, and operational uncertainty have slowed market entry of regenerative medicine treatments. As a result, commercial development has often been led by entrepreneurial ventures rather than large biopharma firms. Translating regenerative medicine across the university-industry boundary links academic scientists, technology transfer organizations, funders, and entrepreneurs. Conflicting motivations among the participants may significantly hinder these efforts. Unproven downstream business models for regenerative medicine delivery further complicate the entrepreneurial process. This chapter explores the challenges associated with entrepreneurial activity commercializing regenerative medicine science developed at research institutions.

View on publisher site
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
 Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 21%
Lecturer 3 13%
Student > Ph. D. Student 3 13%
Student > Master 2 8%
Student > Doctoral Student 1 4%
Other 4 17%
Unknown 6 25%
Readers by discipline Count As %
Business, Management and Accounting 3 13%
Economics, Econometrics and Finance 2 8%
Biochemistry, Genetics and Molecular Biology 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Nursing and Health Professions 1 4%
Other 5 21%
Unknown 10 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2018.
All research outputs
#15,545,785
of 23,103,903 outputs
Outputs from Advances in experimental medicine and biology
#2,528
of 4,976 outputs
Outputs of similar age
#215,438
of 341,592 outputs
Outputs of similar age from Advances in experimental medicine and biology
#36
of 69 outputs
Altmetric has tracked 23,103,903 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,976 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,592 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.

This page is provided by Altmetric.